# Self-Administered Intralesional Injections for Acne

> **NCT06186596** · NA · UNKNOWN · sponsor: **ACOM Labs** · enrollment: 150 (estimated)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DEVICE:** Triamcinolone delivered via injection assistance device

## Key facts

- **NCT ID:** NCT06186596
- **Lead sponsor:** ACOM Labs
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02-01
- **Primary completion:** 2024-01-31
- **Final completion:** 2024-01-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2024-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06186596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06186596, "Self-Administered Intralesional Injections for Acne". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06186596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*